Cargando…

Comparative biochemical analysis of wildtype and drug resistant HIV-1 integrase subtypes B and C

Detalles Bibliográficos
Autores principales:	Bar-Magen, Tamara, Sloan, Richard D, McDonough, Emily I, Faltenbacher, Verena, Donahue, D Aaron, Kuhl, Bjorn D, Xu, Hongtao, Wainberg, Mark A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767045/ http://dx.doi.org/10.1186/1742-4690-6-S2-P6

Ejemplares similares

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes
por: Bar-Magen, Tamara, et al.
Publicado: (2009)

Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1
por: Kuhl, BD, et al.
Publicado: (2010)

Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes
por: Sloan, Richard D, et al.
Publicado: (2010)

HIV entry blocked by maraviroc can cause an overestimation of viral load
por: Sloan, RD, et al.
Publicado: (2010)

Tetherin restricts direct cell-to-cell infection of HIV-1
por: Kuhl, Björn D, et al.
Publicado: (2010)

Cell-to-cell transmission of HIV-1 between CD4(+)T-cells involves clathrin-mediated endocytosis
por: Sloan, Richard D, et al.
Publicado: (2011)

Novel therapeutic strategies targeting HIV integrase
por: Quashie, Peter K, et al.
Publicado: (2012)

Latent HIV-1 can be reactivated by superinfection in a Tat-dependent manner, which can lead to the emergence of recombinant viruses
por: Donahue, Daniel Aaron, et al.
Publicado: (2013)

Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008)

The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism
por: Kuhl, Björn D., et al.
Publicado: (2011)

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

Biochemical and virological analysis of the preference for the K65R multi-resistance nucleoside mutation in subtype C viruses
por: Wainberg, Mark A, et al.
Publicado: (2009)

Prototype Foamy Virus Integrase Displays Unique Biochemical Activities among Retroviral Integrases
por: Rabe, Anthony J., et al.
Publicado: (2021)

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)

Biochemical Characterization of Novel Retroviral Integrase Proteins
por: Ballandras-Colas, Allison, et al.
Publicado: (2013)

Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations
por: Nguyen, Nga, et al.
Publicado: (2013)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
por: Raffi, Francois, et al.
Publicado: (2012)

Biochemical mechanism of clinical resistance to rilpivirine
por: Singh, Kamalendra, et al.
Publicado: (2012)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
por: Mesplède, Thibault, et al.
Publicado: (2015)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Integrase inhibitor-based treatment in clinical practice
por: Cenderello, G, et al.
Publicado: (2010)

HIV-1 integrase SUMOylation and viral replication
por: Zamborlini, Alessia, et al.
Publicado: (2011)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains
por: Chetty, S, et al.
Publicado: (2012)

Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C
por: Xu, Hong-Tao, et al.
Publicado: (2010)

PIAS3 modulate HIV-1 integrase SUMOylation
por: Beauclair, Guillaume, et al.
Publicado: (2011)

Biochemical activity of RAGs is impeded by Dolutegravir, an HIV integrase inhibitor
por: Nilavar, Namrata M., et al.
Publicado: (2020)

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
por: Wainberg, Mark A.
Publicado: (2012)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors
por: Ni, Xiaoju, et al.
Publicado: (2012)

High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment
por: El Bouzidi, Kate, et al.
Publicado: (2020)

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review
por: Hassounah, Said A., et al.
Publicado: (2016)

HIV-1 subtype C viruses rapidly develop K65R
por: Wainberg, Mark A, et al.
Publicado: (2006)

Updates in IDH-Wildtype Glioblastoma
por: Melhem, Jawad M., et al.
Publicado: (2022)

Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
por: Dinh, Long Phi, et al.
Publicado: (2022)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

Monoclonal antibodies that recognize important functional elements of the HIV-1 integrase enzyme
por: Maroun, Richard G, et al.
Publicado: (2012)

GCN5-dependent acetylation of HIV-1 integrase enhances viral integration
por: Terreni, Mariaelena, et al.
Publicado: (2009)

Biochemical characteristics of functional domains using feline foamy virus integrase mutants
por: Yoo, Gwi-woong, et al.
Publicado: (2013)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
por: Rogers, Leonard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0vso6o5stpqq7bm45p4evt2rf1